A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU)
Conditions
Chronic Spontaneous Urticaria
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
Contact: Principal Investigator (Fei Wang)Peking University People's Hospital, Beijing, Beijing, Beijing Municipality, China
Contact: Principal Investigator (cheng Zhou)Contact: Principal Investigator (Jianzhong Zhou)The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Contact: Principal Investigator (Wenlin Yang)Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China
Contact: Principal Investigator (Bin Yang)The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Contact: Principal Investigator (Guoqiang Zhang)Jingzhou Central Hospital, Jinzhou, Hubei, China
Contact: Principal Investigator (YI Sun)Wuxi Second People's Hospital,, Wuxi, Jiangsu, China
Contact: Principal Investigator (Xunyi Dai)The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
Contact: Principal Investigator (Wenli Feng)The Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
Contact: Principal Investigator (Songmei Geng)Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China
Contact: Principal Investigator (Xingang WU)